Hap Trading, LLC Infinity Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.46 - $1.21 $3,220 - $8,470	-7,000 Reduced 36.84%	12,000 $0
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.7 $590 - $1,700	1,000 Added 5.56%	19,000 $1,000
Q2 2022 Aug 12, 2022	BUY	$0.49 - $1.2 $2,303 - $5,640	4,700 Added 35.34%	18,000 $1,000
Q1 2022 May 12, 2022	SELL	$0.85 - $2.4 $29,920 - $84,480	-35,200 Reduced 72.58%	13,300 $3,000
Q4 2021 Feb 14, 2022	BUY	$1.86 - $3.36 $34,410 - $62,160	18,500 Added 61.67%	48,500 $7,000
Q3 2021 Nov 10, 2021	BUY	$1.52 - $3.82 $27,512 - $69,142	18,100 Added 152.1%	30,000 $11,000
Q2 2021 Aug 11, 2021	BUY	$2.66 - $3.47 $31,654 - $41,293	11,900 New	11,900 $3,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.